Compare J.B.Chemicals with Divis Laboratories - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs DIVIS LABORATORIES - Comparison Results

J.B.CHEMICALS     Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DIVIS LABORATORIES 
   Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS DIVIS LABORATORIES J.B.CHEMICALS/
DIVIS LABORATORIES
 
P/E (TTM) x 16.8 32.7 51.3% View Chart
P/BV x 2.3 7.4 31.4% View Chart
Dividend Yield % 0.5 0.6 83.4%  

Financials

 J.B.CHEMICALS   DIVIS LABORATORIES
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-18
DIVIS LABORATORIES
Mar-18
J.B.CHEMICALS/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs3631,142 31.8%   
Low Rs255533 47.8%   
Sales per share (Unadj.) Rs169.1146.6 115.4%  
Earnings per share (Unadj.) Rs16.633.0 50.2%  
Cash flow per share (Unadj.) Rs23.438.4 61.0%  
Dividends per share (Unadj.) Rs2.0010.00 20.0%  
Dividend yield (eoy) %0.61.2 54.2%  
Book value per share (Unadj.) Rs172.5222.8 77.4%  
Shares outstanding (eoy) m83.57265.47 31.5%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x1.85.7 32.0%   
Avg P/E ratio x18.625.3 73.4%  
P/CF ratio (eoy) x13.221.8 60.5%  
Price / Book Value ratio x1.83.8 47.7%  
Dividend payout %12.030.3 39.8%   
Avg Mkt Cap Rs m25,827222,318 11.6%   
No. of employees `0003.810.8 35.0%   
Total wages/salary Rs m2,5114,561 55.1%   
Avg. sales/employee Rs Th3,747.43,616.0 103.6%   
Avg. wages/employee Rs Th665.7423.8 157.1%   
Avg. net profit/employee Rs Th367.8814.9 45.1%   
INCOME DATA
Net Sales Rs m14,13538,915 36.3%  
Other income Rs m3661,134 32.2%   
Total revenues Rs m14,50140,049 36.2%   
Gross profit Rs m2,17812,617 17.3%  
Depreciation Rs m5701,425 40.0%   
Interest Rs m3513 262.4%   
Profit before tax Rs m1,94012,313 15.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5523,543 15.6%   
Profit after tax Rs m1,3878,770 15.8%  
Gross profit margin %15.432.4 47.5%  
Effective tax rate %28.528.8 99.0%   
Net profit margin %9.822.5 43.5%  
BALANCE SHEET DATA
Current assets Rs m10,47045,351 23.1%   
Current liabilities Rs m2,7496,507 42.2%   
Net working cap to sales %54.699.8 54.7%  
Current ratio x3.87.0 54.6%  
Inventory Days Days55127 43.6%  
Debtors Days Days7895 81.6%  
Net fixed assets Rs m5,81121,160 27.5%   
Share capital Rs m167531 31.5%   
"Free" reserves Rs m14,24858,625 24.3%   
Net worth Rs m14,41659,156 24.4%   
Long term debt Rs m00-   
Total assets Rs m17,64967,832 26.0%  
Interest coverage x56.6926.8 6.1%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.6 139.6%   
Return on assets %8.112.9 62.2%  
Return on equity %9.614.8 64.9%  
Return on capital %13.720.8 65.7%  
Exports to sales %00-   
Imports to sales %021.8 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA8,485 0.0%   
Fx inflow Rs m6,16432,359 19.0%   
Fx outflow Rs m1,3349,042 14.8%   
Net fx Rs m4,82923,317 20.7%   
CASH FLOW
From Operations Rs m1,2317,759 15.9%  
From Investments Rs m-208-4,783 4.4%  
From Financial Activity Rs m-595-3,142 18.9%  
Net Cashflow Rs m427-166 -257.3%  

Share Holding

Indian Promoters % 55.4 52.0 106.5%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 11.8 28.7%  
FIIs % 3.9 19.0 20.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 17.2 215.1%  
Shareholders   30,437 31,796 95.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   BIOCON   WOCKHARDT  AUROBINDO PHARMA  PLETHICO PHARMA  FDC LTD.  

Compare J.B.CHEMICALS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 262 Points Lower; Oil & Gas and Banking Stocks Witness Selling(Closing)

Indian share markets witnessed negative trading activity throughout the day and ended lower. At the closing bell, the BSE Sensex stood lower by 262 points (down 0.7%).

Related Views on News

DIVIS LABORATORIES Announces Quarterly Results (1QFY20); Net Profit Up 0.4% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 0.4% YoY). Sales on the other hand came in at Rs 11 bn (up 14.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (4QFY19); Net Profit Up 10.6% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 10.6% YoY). Sales on the other hand came in at Rs 13 bn (up 15.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

DIVIS LABORATORIES Announces Quarterly Results (3QFY19); Net Profit Up 68.9% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (up 68.9% YoY). Sales on the other hand came in at Rs 13 bn (up 29.4% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Insider Buying Alert: Promoters Increase Stake in 8 High-Quality Smallcaps(Profit Hunter)

Sep 3, 2019

Insiders have increased their stakes in eight Hidden Treasure recommendations. Should you follow them?

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Sep 16, 2019 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 8-QTR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS